Aarti Drugs Limited has informed the Exchange about General Updates
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has informed the stock exchanges that its subsidiary, Pinnacle Chile SpA, has incorporated a new wholly owned overseas subsidiary named Tripharma Chile SpA in Chile on February 27, 2026. The new entity will focus on marketing formulation drugs and participating in tenders and the private market in Chile, which is in line with the existing business of the holding companies. Tripharma Chile SpA will be 100% held by Pinnacle Chile SpA, making it a step-down subsidiary of Aarti Drugs. The investment was made via cash consideration of Chilean Peso 10,00,000 (10 lakh Chilean Pesos) as share capital contribution.
This is a minor international expansion move into the Chilean pharmaceutical market through a wholly owned step-down subsidiary. While it signals Aarti Drugs' interest in growing its overseas footprint, the financial outlay is small and unlikely to materially impact the stock in the near term.